Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TFC-003 in Glaucoma or Ocular Hypertension
NCT06177678Phase 2Not yet recruiting
- Sponsor
- Kukje Pharm
- Start
- Feb 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of TFC-003 in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Kukje Pharm. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
TFC-003
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT06177678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06177678.